Australia to allow prescription of MDMA and psilocybin for treatment-resistant mental illnesses
psilocybin
The Top 10 Psychedelic Science Studies Of 2022
Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial
This research paper has been published in eClinicalMedicine. The summary says: “Background Psilocybin has been suggested as a novel, rapid-acting treatment for depression. Two consecutive doses have been shown to markedly decrease symptom severity in an open-label setting or when compared to…
Read more
Magic-mushroom drug can treat severe depression, trial suggests
New study determines psychedelic mushroom microdoses can improve mood, mental health
As reported on the MedicalXpress website, research from the University of British Columbia is … “The latest study to examine how tiny amounts of psychedelics can impact mental health provides further evidence of the therapeutic potential of microdosing. Published in Scientific Reports this…
Read more
Psychedelic frees up depressed brain, study shows
Psilocybin: British study finds ‘magic mushroom’ drug can be safely used to treat depression
Relational Psychotherapy and Psychedelic Treatment
The Psychedelic Drug Trial
This 1 hour documentary film is from BBC2. The makers say: “The Psychedelic Drug Trial has exclusive access to a ground-breaking new trial at Imperial College London. The trial sees, for the first time ever under controlled conditions, a psychedelic drug tested…
Read more
Psilocybin: Magic mushroom compound ‘promising’ for depression
Rachel Schraer reports for the BBC: “Dr Carhart-Harris said that after psychedelic therapy, participants reported feeling ‘recalibrated, reset like they haven’t for years” and “enjoying life’.” “Psychedelic drug psilocybin, found in magic mushrooms, is as good at reducing symptoms of depression…
Read more